What's Changed With Express Scripts?

The largest pharmacy benefit manager in the country, Express Scripts , has seen its shares fall under serious pressure since reporting earnings. To keep investors up to speed with the stock, Motley Fool health care bureau chief Brenton Flynn breaks down some of the key changes to the company's latest SEC filings and compares his findings with the commentary from one of its big customers, UnitedHealth Group .

Express Scripts have been hit hard since that earnings report. Has the company's long-term outlook really changed, or is this a classic example of Wall Street being blinded by its short-term lens? In this brand new premium report on Express Scripts, Stock Advisor analyst Jim Mueller dives deep into the company's prospects. Here's a hint: There's plenty of room for growth. You'll understand why, along with an outline of the key must-watch areas of the company, if you claim a copy by clicking here now.

The article What's Changed With Express Scripts? originally appeared on Fool.com.

Brenton Flynn has no positions in the stocks mentioned above. Max Macaluso has no positions in the stocks mentioned above. The Motley Fool owns shares of Express Scripts. Motley Fool newsletter services recommend Express Scripts and UnitedHealth Group. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.